Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation.

Mallea-Gil MS, Bernabeu I, Spiraquis A, Avangina A, Loidi L, Ballarino C

Open source

DOI
10.1155/2016/2087102
Published
2016
Container
Case reports in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2016/2087102,
  title = {Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation.},
  author = {Mallea-Gil MS and Bernabeu I and Spiraquis A and Avangina A and Loidi L and Ballarino C},
  year = {2016},
  journal = {Case reports in endocrinology},
  doi = {10.1155/2016/2087102},
  url = {https://doi.org/10.1155/2016/2087102}
}

RIS

TY  - JOUR
TI  - Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation.
AU  - Mallea-Gil MS
AU  - Bernabeu I
AU  - Spiraquis A
AU  - Avangina A
AU  - Loidi L
AU  - Ballarino C
PY  - 2016
JO  - Case reports in endocrinology
DO  - 10.1155/2016/2087102
UR  - https://doi.org/10.1155/2016/2087102
ER  - 

APA

MS, M., I, B., A, S., A, A., L, L., & C, B. (2016). Pegvisomant-Induced Cholestatic Hepatitis in an Acromegalic Patient with UGT1A1 (⁎) 28 Mutation.. Case reports in endocrinology. https://doi.org/10.1155/2016/2087102

Source records